![Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity | Scientific Reports Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-06022-z/MediaObjects/41598_2022_6022_Fig1_HTML.png)
Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity | Scientific Reports
![Optimizing Management of MAC Lung Disease with Guideline-Based Therapy<br><sub>Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD</sub> - CMEducation Resources symposium Optimizing Management of MAC Lung Disease with Guideline-Based Therapy<br><sub>Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD</sub> - CMEducation Resources symposium](http://res.cloudinary.com/broadcastmed/image/fetch/q_auto,c_fill,w_1300,h_731,g_faces:center,f_auto/http%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2ForlVideoAssets%2FimgSource%2Fers-mac-lung-disease-banner-email-524-session-3.jpg)
Optimizing Management of MAC Lung Disease with Guideline-Based Therapy<br><sub>Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD</sub> - CMEducation Resources symposium
![First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81025-w/MediaObjects/41598_2021_81025_Fig1_HTML.png)
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports
![First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81025-w/MediaObjects/41598_2021_81025_Fig1_HTML.png)
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports
![Optimizing Management of MAC Lung Disease with Guideline-Based Therapy - CMEducation Resources symposium Optimizing Management of MAC Lung Disease with Guideline-Based Therapy - CMEducation Resources symposium](http://res.cloudinary.com/broadcastmed/image/fetch/q_auto,c_fill,w_1300,h_731,g_faces:center,f_auto/http%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2ForlVideoAssets%2FimgSource%2Fers-symposium_daley_formatted_session-two.png)
Optimizing Management of MAC Lung Disease with Guideline-Based Therapy - CMEducation Resources symposium
![Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis | Respiratory Research | Full Text Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-019-1258-9/MediaObjects/12931_2019_1258_Fig1_HTML.png)